Brachytherapy in head and neck cancers;Curiethérapie des cancers de la sphère ORL

Cancer/Radiotherapie

Volumn 7, Issue 1, 2003, Pages 62-72

  Mazeron, J J ^a   Noel G ^a   Simon, J M ^a   Racadot, S ^a   Jauffret, E ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Brachytherapy; Head and neck cancer; Iridium 192; Nasopharynx; Oral cavity; Oropharynx

Indexed keywords

IRIDIUM 192;

BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; HEAD AND NECK CANCER; HUMAN; MANDIBLE; MASTICATION; MOUTH CAVITY; NASOPHARYNX; OROPHARYNX; PRIORITY JOURNAL; RADIATION BEAM; RADIATION DOSE; REVIEW; SALIVARY GLAND; TREATMENT OUTCOME;

EID: 18844475891     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(02)00286-X     Document Type: Review

References (42)

1. Ash D. Interstitial therapy. Acta Radiol 1986;16:369-93.
2. Benk V, Mazeron JJ, Grimard L, Crook J, Haddad E, Piedbois P, et al. Comparison of curietherapy versus external irradiation in Stage II squamous cell carcinoma of the mobile tongue. Radiother Oncol 1990;18:339-47.
3. Chang JT, See LC, Tang SGJ, Lee SP, Wang CC, Hong JH. The role of brachytherapy in early stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1996;36:1019-24.
4. Chassagne D, Janvier L, Pierquin B, Flaisler A. La plésiocuriethérapie des cancers du cavum avec support-moule et iridium 192. Ann Radiol 1983;6:719-26.
5. Chu A, Fletcher GH. Incidences and causes of failure to control by irradiation the primary lesion in squamous cell carcinomas of the anterior two thirds of the tongue and floor of mouth. Am J Roentgenol 1973;117:502-8.
6. Crook J, Mazeron JJ, Marinello G, Martin M, Raynal M, Calitchi E, et al. Combined external and interstitial implantation for T1 and T2 epidermoid carcinoma of base of tongue: the Créteil experience. Int J Radiat Oncol Biol Phys 1988;15:105-14.
7. Gerbaulet A, Pernot A. Cancer of the buccal mucosa, Proccedings of the 20th annual meeting of the European Curietherapy Group. J Eur Radiother 1985;6:1-4.
8. Gerbaulet A, Pötter R, Mazeron JJ, Mertens H, Van Limbergen E. The Gec Estro Handbook of brachytherapy. Bruxelles: Estro; 2002.
9. Grimard L, Mazeron JJ, Pierquin B. Comparison of curietherapy versus external irradiation combined with curietherapy in Stage II squamous cell carcinomas of the floor of mouth. Endocur Hypertherm Oncol 1991;7:97-110.
10. Harrison LB, Weissenberg JB. A technique for interstitial nasopharyngeal brachytherapy. Int J Radiat Oncol Biol Phys 1987;13:451-3.
11. Harrison LB, Zelefsky MJ, Armstrong JG, Carper E, Gaynor JJ, Sessions RB. Performance status after treatment for squamous cell cancer of base of tongue - A comparison of primary radiation therapy versus primary surgery. Int J Radiat Oncol Biol Phys 1994;30:953-7.
12. Henschke UK, James AG, Myers WG. Radiogold seeds in cancer therapy. Nucleonics 1953;11(46).
13. Housset M, Baillet F, Dessard-Diana B, Martin D, Miglianico L. A retrospective analysis of three treatment techniques for T1-2 base of tongue lesions: surgery plus postoperative irradiation, external irradiation plus interstitial implantation and external irradiation alone. Int J Radiat Oncol Biol Phys 1987;13:511-6.
14. Inoue T, Teshima T, Murayama S, Shumizutani K, Fuchihata H, Furukawa S. Phase III trial of high and low dose rate interstitial radiotherapy for early oral tongue cancer. Int J Radiat Oncol Biol Phys 1996;36:1201-4.
15. Langlois D, Hoffsteitter S, Malissard L, Pernot M, Taghian A. Salvage irradiation of oropharynx and mobile tongue about iridium brachytherapy in Centre Alexis Vautrin. Int J Radiat Oncol Biol Phys 1988;14:849-53.
16. Lapeyre M, Peiffert D, Malissard L, Hoffstetter S, Pernot M, et al. An original technique of brachytherapy in the treatment of epidermoid carcinomas of the buccal mucosa. Int J Radiat Oncol Biol Phys 1995;33:447-54.
17. Lau HY, Hay JH, Flores AD, Threlfall WJ: Seven fractions of twice daily high dose-rate brachytherapy for node negative carcinoma of the mobile tongue results in loss of therapeutic ratio. Radiother Oncol 1996;39:19-29.
18. Levendag PC, Peters R, Meeuwis CA, Visch LL, Sipkema D, De Pan C, et al. A new applicator design for endocavitary brachytherapy of cancer of nasopharynx. Radiother Oncol 1997;45:95-8.
19. Levendag PC, Schmitz PIM, Jansen PJ, Senan S, Eijkenboom WM, Sipkema D, et al. Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate. Int J Radiat Oncol Biol Phys 1997;38:497-506.
20. Mazeron JJ, Richaud P. Lip cancer, Report of the 18th annual meeting of the European Curietherapy Group, May 1981. J Eur Radiother 1984;5:50-6.
21. Mazeron JJ, Langlois D, Glaubiger D, Huart J, Martin M, Raynal M, et al. Salvage irradiation of oropharyngeal cancers using Iridium 192 wire implants: 5-year results of 70 cases. Int J Radiat Oncol Biol Phys 1987;13:957-62.
22. Mazeron JJ, Grimard L, Raynal M, Haddad E, Piedbois P, Martin M, et al. Iridium-192 for T1 and T2 epidermoid carcinomas of the floor of mouth. Int J Radiat Oncol Biol Phys 1990;18:1299-306.
23. Mazeron JJ, Crook JM, Benk V, Marinello G, Martin M, Raynal M, et al. Iridium 192 implantation of T1 and T2 epidermoid carcinomas of the mobile tongue. Int J Radiat Oncol Biol Phys 1990;19:1369-76.
24. Mazeron JJ, Simon JM, Le Péchoux C, Crook J, Grimard L, Piedbois P, et al. Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinoma of mobile tongue and floor of mouth with interstitial iridium 192. Radiother Oncol 1991;21:39-47.
25. Mazeron JJ, Belkacemi Y, Simon JM, Le péchoux C, Martin M, Haddad E, et al. Place of iridium 192 implantation in definitive irradiation of faucial arch squamous cell carcinomas. Int J Radiat Oncol Biol Phys 1993;27:251-7.
26. Mendenhall WM, Parsons JM, Stringer SP, Cassisi NJ, Million RR. T2 oral tongue carcinoma treated with radiotherapy; analysis of local control and complications. Radiother Oncol 1989;16:275-81.
27. Meredith JW. Radium dosage, The Manchester System. London: Livington; 1967.
28. Peiffert D, Castelain B, Thomas L, Ardiet JM, Baillet F, Mazeron JJ. Pulsed dose rate brachytherapy in head and neck cancers, Feasibility study of a French cooperative group. Radiother Oncol 2001;58:71-5.
29. Pernot M, Malissart L, Aletti P, Hoffstetter S, Forçard JJ, Bey P. Iridium-192 brachytherapy in the management of 147 T2N0 oral tongue carcinomas treated with irradiation alone; comparison of two treatment techniques. Radiother Oncol 1992;23:223-8.
30. Pernot M, Malissard L, Hoffstetter S, Luporsi E, Peiffert D, Aletti P, et al. The study of tumoral, radiobiological, and general health factors that influence results and complications in a series if 448 oral tongue carcinomas treated exclusively by irradiation. Int J Radiat Oncol Biol Phys 1994;29:673-9.
31. Pernot M, Malissard L, Hoffstetter S, Guillemenin F, Luporski E, Hoffstetter S, et al. Influence of tumoral, radiobiological and general health factors on local control and survival of a series of 361 tumors of the velo-tonsillar area treated by exclusive irradiation (external beam irradiation + brachytherapy or brachytherapy alone). Int J Radiat Oncol Biol Phys 1994;30:1021-7.
32. Pernot M, Hoffstetter S, Peiffert D, Luporsi E, Marchal C, Kozminski P, et al. Epidermoid carcinomas of the floor of mouth treated by exclusive irradiation: statistical study of a series of 207 cases. Radiother Oncol 1995;35:177-85.
33. Pernot M, Luporsi E, Hoffsteitter S, Luporski E, Marchal C, Kozminski, et al. Complications following definitive irradiation of the oral cavity and the oropharynx (in a series of 1134 patients). Int J Radiat Oncol Biol Phys 1997;37:577-85.
34. Piedbois P, Mazeron JJ, Haddad E, Coste A, Lévy C, Raynal M, et al. Stage I-II squamous cell carcinoma of the oral cavity treated by Iridium 192: is elective dissection indicated? Radiother Oncol 1991;21:100-7.
35. Pryzant RM, Wendt CD, Delclos L, Peters LJ. Re-treatment of nasopharyngeal carcinoma in 53 patients. Int J Radiat Oncol Biol Phys 1992;22:941-7.
36. Puthawala AA, Syed AMN, Eads DL, Eads DL, Gillin L, Gates TC. Limited external beam interstitial 192 Iridium irradiation in the treatment of carcinoma of the base of tongue: a ten year experience. Int J Radiat Oncol Biol Phys 1988;14:839-48.
37. Sehti T, Ash DV, Flynn A, Workman G. Replacement of hairpin and loop implants by optimised straight line sources. Radiother Oncol 1996;39:117-21.
38. Simon JM, Mazeron JJ, Pohar S, Le Péchoux C, Crook JM, Grimard L, et al. Effect of intersource spacing on local control and complications in brachytherapy of mobile tongue and floor of mouth. Radiother Oncol 1993;26:19-25.
39. Vandenbrouck C, Sancho-Garnier H, Chassagne D, Saravane D, Cachin Y, et al. Elective versus therapeutic neck dissection in epidermoid carcinoma of the oral cavity. Cancer 1980;46:386-90.
40. Vikram B, Hilaris B. Transnasal permanent implantation for carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys 1984;10:153-5.
41. Wang CC. Radiation Therapy for Head and Neck Neoplasms. Third Edition. New York: Wiley-Liss; 1997.
42. Wendt CD, Peters LJ, Delclos L, Ang KK, Morisson WH, Maor MJ, et al. Primary radiotherapy in the treatment of Stage I and II oral tongue cancers: importance of the proportion of therapy delivered with interstitial therapy. Int Radiat Oncol Biol Phys 1995;18:1287-98.